Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 45 Neoplasm Metastasis 6 Glioma 6 Glioblastoma 6 Neoplasms 5 Brain Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Sarcoma 3 Ovarian Neoplasms 3 Liposarcoma 3 Diffuse Intrinsic Pontine Glioma 3 Astrocytoma 3 Recurrence 2 Prostatic Neoplasms 2 Meningioma 2 Medulloblastoma 2 Fallopian Tube Neoplasms 2 Breast Neoplasms, Male 2 Breast Cancer Metastatic 2 Venous Thromboembolism 1 Triple Negative Breast Neoplasms 1 Thymus Neoplasms 1 Sarcoma, Synovial 1 Rhabdoid Tumor 1 Pyloric Stenosis, Hypertrophic 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pinealoma 1 Oligodendroglioma 1 Non functioning pancreatic endocrine tumor 1 Neurofibrosarcoma 1

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × HER2 Negative Breast Cancer × ribociclib × Clear all

NCT06953882 2026-05-26

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡